Home
Live Updates
FDA Panel Says No to Experimental ALS Drug : comparemela.com
FDA Panel Says No to Experimental ALS Drug
THURSDAY, Sept. 28, 2023 (HealthDay News) – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS.
Related Keywords
Virginia ,
United States ,
Lisa Lee ,
Matt Klingenberg ,
Cara Murez ,
Lou Gehrig ,
Kenneth Fischbeck ,
Mitze Klingenberg ,
Drug Administration On ,
Associated Press ,
National Institutes Of Neurological Disorders ,
Healthday News ,
Drug Administration ,
Virginia Tech ,
Hereditary Neurological Diseases ,
National Institutes ,
Neurological Disorders ,
Dcc ,
Fire ,
Tncen ,
Ealth And Wellness ,
Ealthday ,
Consumer News ,
Medicine ,
Rade ,
The Press ,
Harmacology ,
Natomy ,
Politics ,
Ob Market ,
comparemela.com © 2020. All Rights Reserved.